TPX2 and neoplasm: The down-regulation of TPX2 expression in tumor-infiltrating CD8+ T lymphocytes in HCC leads to the inactivation of the NF-κB signaling pathway, resulting in a weakened anti-tumor effect of these lymphocytes (237).